Virax Biolabs Group Ltd Adjustments For Decrease Increase In Prepaid Expenses
Virax Biolabs Group Ltd (VRAX) reported Adjustments For Decrease Increase In Prepaid Expenses of -$26.60 thousand for the 12-month period ending 2025-03-31, per its 20-F filed 2025-07-02.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:AdjustmentsForDecreaseIncreaseInPrepaidExpenses · last filed 2025-07-02
| Period end | Adjustments For Decrease Increase In Prepaid Expenses 12 month |
|---|---|
| 2025-03-31 | -$26.60K 20-F · filed 2025-07-02 |
| 2024-03-31 | -$231.31K 20-F · filed 2025-07-02 |
| 2023-03-31 | -$275.48K 20-F · filed 2025-07-02 |
| 2022-03-31 | $2.19K 20-F · filed 2024-08-20 |